mr 2034 has been researched along with butorphanol in 2 studies
Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (butorphanol) | Trials (butorphanol) | Recent Studies (post-2010) (butorphanol) |
---|---|---|---|---|---|
48 | 0 | 0 | 1,233 | 395 | 382 |
Protein | Taxonomy | mr 2034 (IC50) | butorphanol (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hart, JC; Leander, JD; Zerbe, RL | 1 |
Gmerek, DE; Woods, JH | 1 |
2 other study(ies) available for mr 2034 and butorphanol
Article | Year |
---|---|
Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Butorphanol; Cyclazocine; Diuresis; Drinking; Ethylketocyclazocine; Female; Male; Nalorphine; Pyrrolidines; Rats; Rats, Inbred Strains; Rats, Zucker; Receptors, Opioid; Receptors, Opioid, kappa; Stereoisomerism; Vasopressins; Water Deprivation | 1987 |
Substitution and primary dependence studies in animals.
Topics: Animals; Behavior, Animal; Benzomorphans; Buprenorphine; Butorphanol; Codeine; Discrimination, Psychological; Humans; Macaca mulatta; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Narcotic Antagonists; Pentazocine; Piperidines; Substance Withdrawal Syndrome | 1985 |